..@nextstrain (Auspice + Augur) and @GISAID (EpiFlu + EpiCoV) have worked together to revolutionize how we understand outbreaks and have led to virtuous cycles of enhanced genome sequencing around the world 🌍
There are great things in store for all of us when we each get past our disagreements and/ or misunderstandings...
Should @Tuliodna and @houzhou be “reimbursed” for “filling the void,” too.. and discovering B.1.351 and many other emergent variants? Is that our role? A raw materials producers those like you who refine pretty phylogenetic trees?
Or maybe local virologists want to engage with their local & international collaborators like @VirusWhisperer to develop viral neutralization assays?
Francis Collins discussed our work (positively) with the Washington Post.. and your boss, Greg Armstrong, presented to on the Q677 variants we helped discover
But we have seen no direct support from @CDCgov@CDCemergency@CDCDirector ... instead you take Louisiana $$$ and send it to @Labcorp & Quest & Illumina and stamp your name as SENIOR AUTHOR every time they publish a sequence under the CDC contracts you cut for them.
Sequencing pathogens & sharing the data is a public health utility. It needs to be distributed and decentralized to avoid the next COVID-19. And also, let’s face it.. to modernize how we move forward against all community transmitted infectious diseases.
Academia has huge role in community outreach, education & microbial genomic surveillance. CDC OAMD support for this has been ALL TALK. NO WALK.
In the near future, ongoing community-based surveillance sequencing will release daily / weekly reports on the viruses 🦠 and bacteria that are actively causing illnesses in our schools, workplaces, care homes, et cetera
We now have testing + sequencing 💪🏼 + technology + talent to test, trace, predict, vaccinate, and/or treat or defeat a vast many different COSTLY viral diseases and antibiotic-resistant bacterial infections.
Science and technology are ready to deploy globally 🌍. And will fuel a wave of outreach, education, not to mention save countless lives. But do we have the will and the right ideas to make it a reality?
As much as I applaud Gamaleya for developing an efficacious vaccine, this tweet and the associated links are not a scientifically accurate characterization of our findings (to be as diplomatic as I know how).
it's a favorite article of mine.. In fact, I always try to wheedle the medical students into reading it when I lecture on viral pathogenesis..and it's funny to realize it must have been some years since I read it in full.
so much admiration for the incredible journeys of imagination, curiosity, and hard work that goes into solving these riddles..
She works at an academic medical center rooted in the NYC community. Yet @nycHealthy finds a way to spend New Yorker’s money contracting with a for-profit outfit instead of working with people like and her team @nyulangone or another at @IcahnMountSinai